Unknown

Dataset Information

0

Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.


ABSTRACT: Activating mutations in KRAS occur in 30% to 40% of colorectal cancers. How mutant KRAS alters cancer cell behavior has been studied intensively, but non-cell autonomous effects of mutant KRAS are less understood. We recently reported that exosomes isolated from mutant KRAS-expressing colon cancer cells enhanced the invasiveness of recipient cells relative to exosomes purified from wild-type KRAS-expressing cells, leading us to hypothesize mutant KRAS might affect neighboring and distant cells by regulating exosome composition and behavior. Herein, we show the results of a comprehensive proteomic analysis of exosomes from parental DLD-1 cells that contain both wild-type and G13D mutant KRAS alleles and isogenically matched derivative cell lines, DKO-1 (mutant KRAS allele only) and DKs-8 (wild-type KRAS allele only). Mutant KRAS status dramatically affects the composition of the exosome proteome. Exosomes from mutant KRAS cells contain many tumor-promoting proteins, including KRAS, EGFR, SRC family kinases, and integrins. DKs-8 cells internalize DKO-1 exosomes, and, notably, DKO-1 exosomes transfer mutant KRAS to DKs-8 cells, leading to enhanced three-dimensional growth of these wild-type KRAS-expressing non-transformed cells. These results have important implications for non-cell autonomous effects of mutant KRAS, such as field effect and tumor progression.

SUBMITTER: Demory Beckler M 

PROVIDER: S-EPMC3567858 | biostudies-other | 2013 Feb

REPOSITORIES: biostudies-other

altmetric image

Publications

Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.

Demory Beckler Michelle M   Higginbotham James N JN   Franklin Jeffrey L JL   Ham Amy-Joan AJ   Halvey Patrick J PJ   Imasuen Imade E IE   Whitwell Corbin C   Li Ming M   Liebler Daniel C DC   Coffey Robert J RJ  

Molecular & cellular proteomics : MCP 20121115 2


Activating mutations in KRAS occur in 30% to 40% of colorectal cancers. How mutant KRAS alters cancer cell behavior has been studied intensively, but non-cell autonomous effects of mutant KRAS are less understood. We recently reported that exosomes isolated from mutant KRAS-expressing colon cancer cells enhanced the invasiveness of recipient cells relative to exosomes purified from wild-type KRAS-expressing cells, leading us to hypothesize mutant KRAS might affect neighboring and distant cells b  ...[more]

Similar Datasets

| S-EPMC6678395 | biostudies-literature
| S-EPMC5125100 | biostudies-literature
| S-EPMC10753066 | biostudies-literature
| S-EPMC6945285 | biostudies-literature
| S-EPMC4412529 | biostudies-literature
| S-EPMC4735771 | biostudies-other
| S-EPMC5178827 | biostudies-literature
| S-EPMC6414436 | biostudies-literature
| S-EPMC8732282 | biostudies-literature
| S-EPMC5216991 | biostudies-literature